Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Secondary Outcome: Secondary Outcomes: Changes in waist circumference, body fat, body lean mass, and metabolic risk factors including levels of plasma glucose, insulin sensitivity, serum lipids, and blood pressure Statistical Analysis Full details previously published 2 and can also be found in the STEP group statistical analysis plan at NEJM.org Statistical analysis approach sought strong control for type I error All endpoints addressing intervention efficacy were analyzed using intention-to-treat approach All endpoints addressing intervention safety were analyzed using per-protocol approach Efficacy endpoints analyzed using 2 estimands Treatment Policy Estimand: intention to treat analysis
GLP-1 is closing the same gap from a biology angle
Yu Tahara, Waseda University, Japan Updates Copyright 2021 Wang, Duan, Huang, Pan, Chen and Guo
This genetic disorder has an estimated prevalence that ranges between 1/10,0001/30,000
Some side effects are nausea, stomach cramps, vomiting, diarrhea, loss of appetite, and constipation
